These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17041896)

  • 1. Identification of novel mutations in the human ornithine transcarbamylase (OTC) gene of Korean patients with OTC deficiency and transient expression of the mutant proteins in vitro.
    Kim GH; Choi JH; Lee HH; Park S; Kim SS; Yoo HW
    Hum Mutat; 2006 Nov; 27(11):1159. PubMed ID: 17041896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OTC gene in ornithine transcarbamylase deficiency: clinical course and mutational spectrum in seven Korean patients.
    Lee JH; Kim GH; Yoo HW; Cheon CK
    Pediatr Neurol; 2014 Sep; 51(3):354-359.e1. PubMed ID: 25011434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.
    Caldovic L; Abdikarim I; Narain S; Tuchman M; Morizono H
    J Genet Genomics; 2015 May; 42(5):181-94. PubMed ID: 26059767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency.
    Choi JH; Lee BH; Kim JH; Kim GH; Kim YM; Cho J; Cheon CK; Ko JM; Lee JH; Yoo HW
    J Hum Genet; 2015 Sep; 60(9):501-7. PubMed ID: 25994866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.
    Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M
    Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of seven novel missense mutations, two splice-site mutations, two microdeletions and a polymorphic amino acid substitution in the gene for ornithine transcarbamylase (OTC) in patients with OTC deficiency.
    Climent C; Rubio V
    Hum Mutat; 2002 Feb; 19(2):185-6. PubMed ID: 11793483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new mutations in the ornithine transcarbamylase (OTC) gene in Korean families.
    Yoo HW; Kim GH; Lee DH
    J Inherit Metab Dis; 1996; 19(1):31-42. PubMed ID: 8830175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential.
    Arranz JA; Riudor E; Marco-Marín C; Rubio V
    J Inherit Metab Dis; 2007 Apr; 30(2):217-26. PubMed ID: 17334707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis in nine unrelated Italian patients affected by OTC deficiency: detection of novel mutations in the OTC gene.
    Bisanzi S; Morrone A; Donati MA; Pasquini E; Spada M; Strisciuglio P; Parenti G; Parini R; Papadia F; Zammarchi E
    Mol Genet Metab; 2002 Jun; 76(2):137-44. PubMed ID: 12083811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-frequency detection of deletions and variable rearrangements at the ornithine transcarbamylase (OTC) locus by oligonucleotide array CGH.
    Shchelochkov OA; Li FY; Geraghty MT; Gallagher RC; Van Hove JL; Lichter-Konecki U; Fernhoff PM; Copeland S; Reimschisel T; Cederbaum S; Lee B; Chinault AC; Wong LJ
    Mol Genet Metab; 2009 Mar; 96(3):97-105. PubMed ID: 19138872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant analysis and PGT-M of OTC gene in a Chinese family with ornithine carbamoyltransferase deficiency.
    Zhou Y; Jiang X; Zhang Y; Zhang Y; Sun F; Ma Y
    BMC Pregnancy Childbirth; 2024 Jul; 24(1):491. PubMed ID: 39039447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.
    McCullough BA; Yudkoff M; Batshaw ML; Wilson JM; Raper SE; Tuchman M
    Am J Med Genet; 2000 Aug; 93(4):313-9. PubMed ID: 10946359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The R40H mutation in a late onset type of human ornithine transcarbamylase deficiency in male patients.
    Nishiyori A; Yoshino M; Kato H; Matsuura T; Hoshide R; Matsuda I; Kuno T; Miyazaki S; Hirose S; Kuromaru R; Mori M
    Hum Genet; 1997 Feb; 99(2):171-6. PubMed ID: 9048915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency.
    Climent C; García-Pérez MA; Sanjurjo P; Ruiz-Sanz JI; Vilaseca MA; Pineda M; Campistol J; Rubio V
    Hum Mutat; 1999 Oct; 14(4):352-3. PubMed ID: 10502831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete deletion of ornithine transcarbamylase gene confirmed by CGH array of X chromosome.
    Arranz JA; Madrigal I; Riudor E; Armengol L; Milà M
    J Inherit Metab Dis; 2007 Oct; 30(5):813. PubMed ID: 17570074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic analysis of five Chinese patients with urea cycle disorders.
    Zheng Z; Lin Y; Lin W; Zhu L; Jiang M; Wang W; Fu Q
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1301. PubMed ID: 32410394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of ornithine transcarbamylase gene mutations in three boys affected with late-onset ornithine transcarbamylase deficiency].
    Chen Z; Wen P; Wang G; Liu X; Chen L; Chen S; Wan L; Cui D; Shang Y; Li C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Oct; 31(5):565-9. PubMed ID: 25297582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency.
    Li S; Cai Y; Shi C; Liu M; Liu B; Lin L; Xiao X; Hao H
    Med Sci Monit; 2018 Oct; 24():7431-7437. PubMed ID: 30333473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An arginine to glutamine mutation in residue 109 of human ornithine transcarbamylase completely abolishes enzymatic activity in Cos1 cells.
    Lee JT; Nussbaum RL
    J Clin Invest; 1989 Dec; 84(6):1762-6. PubMed ID: 2556444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ornithine carbamoyltransferase deficiency: molecular characterization of 29 families.
    Storkanova G; Vlaskova H; Chuzhanova N; Zeman J; Stranecky V; Majer F; Peskova K; Luksan O; Jirsa M; Hrebicek M; Dvorakova L
    Clin Genet; 2013 Dec; 84(6):552-9. PubMed ID: 23278509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.